1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Clinical Trials Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Phase I
  • 1.2.3 Phase II
  • 1.2.4 Phase III
  • 1.2.5 Phase IV
• 1.3 Market by Application
  • 1.3.1 Global Clinical Trials Market Share by Application: 2020 VS 2026
  • 1.3.2 Interventional
  • 1.3.3 Observational
  • 1.3.4 Expanded Access
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Clinical Trials Market Perspective (2015-2026)
• 2.2 Global Clinical Trials Growth Trends by Regions
  • 2.2.1 Clinical Trials Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Clinical Trials Historic Market Share by Regions (2015-2020)
  • 2.2.3 Clinical Trials Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Clinical Trials Players by Market Size
  • 3.1.1 Global Top Clinical Trials Players by Revenue (2015-2020)
  • 3.1.2 Global Clinical Trials Revenue Market Share by Players (2015-2020)
• 3.2 Global Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Clinical Trials Revenue
• 3.4 Global Clinical Trials Market Concentration Ratio
  • 3.4.1 Global Clinical Trials Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Clinical Trials Revenue in 2019
• 3.5 Key Players Clinical Trials Area Served
• 3.6 Key Players Clinical Trials Product Solution and Service
• 3.7 Date of Enter into Clinical Trials Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Clinical Trials Breakdown Data by Type (2015-2026)

• 4.1 Global Clinical Trials Historic Market Size by Type (2015-2020)
• 4.2 Global Clinical Trials Forecasted Market Size by Type (2021-2026)

5 Clinical Trials Breakdown Data by Application (2015-2026)

• 5.1 Global Clinical Trials Historic Market Size by Application (2015-2020)
• 5.2 Global Clinical Trials Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Clinical Trials Market Size (2015-2026)
• 6.2 North America Clinical Trials Market Size by Type (2015-2020)
• 6.3 North America Clinical Trials Market Size by Application (2015-2020)
• 6.4 North America Clinical Trials Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Clinical Trials Market Size (2015-2026)
• 7.2 Europe Clinical Trials Market Size by Type (2015-2020)
• 7.3 Europe Clinical Trials Market Size by Application (2015-2020)
• 7.4 Europe Clinical Trials Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Clinical Trials Market Size (2015-2026)
• 8.2 China Clinical Trials Market Size by Type (2015-2020)
• 8.3 China Clinical Trials Market Size by Application (2015-2020)
• 8.4 China Clinical Trials Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Clinical Trials Market Size (2015-2026)
• 9.2 Japan Clinical Trials Market Size by Type (2015-2020)
• 9.3 Japan Clinical Trials Market Size by Application (2015-2020)
• 9.4 Japan Clinical Trials Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Clinical Trials Market Size (2015-2026)
• 10.2 Southeast Asia Clinical Trials Market Size by Type (2015-2020)
• 10.3 Southeast Asia Clinical Trials Market Size by Application (2015-2020)
• 10.4 Southeast Asia Clinical Trials Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Quintiles IMS
  • 11.1.1 Quintiles IMS Company Details
  • 11.1.2 Quintiles IMS Business Overview
  • 11.1.3 Quintiles IMS Clinical Trials Introduction
  • 11.1.4 Quintiles IMS Revenue in Clinical Trials Business (2015-2020))
  • 11.1.5 Quintiles IMS Recent Development
• 11.2 Paraxel International Corporation
  • 11.2.1 Paraxel International Corporation Company Details
  • 11.2.2 Paraxel International Corporation Business Overview
  • 11.2.3 Paraxel International Corporation Clinical Trials Introduction
  • 11.2.4 Paraxel International Corporation Revenue in Clinical Trials Business (2015-2020)
  • 11.2.5 Paraxel International Corporation Recent Development
• 11.3 Charles River Laboratories
  • 11.3.1 Charles River Laboratories Company Details
  • 11.3.2 Charles River Laboratories Business Overview
  • 11.3.3 Charles River Laboratories Clinical Trials Introduction
  • 11.3.4 Charles River Laboratories Revenue in Clinical Trials Business (2015-2020)
  • 11.3.5 Charles River Laboratories Recent Development
• 11.4 ICON plc
  • 11.4.1 ICON plc Company Details
  • 11.4.2 ICON plc Business Overview
  • 11.4.3 ICON plc Clinical Trials Introduction
  • 11.4.4 ICON plc Revenue in Clinical Trials Business (2015-2020)
  • 11.4.5 ICON plc Recent Development
• 11.5 SGS SA
  • 11.5.1 SGS SA Company Details
  • 11.5.2 SGS SA Business Overview
  • 11.5.3 SGS SA Clinical Trials Introduction
  • 11.5.4 SGS SA Revenue in Clinical Trials Business (2015-2020)
  • 11.5.5 SGS SA Recent Development
• 11.6 Pharmaceutical Product Development, LLC
  • 11.6.1 Pharmaceutical Product Development, LLC Company Details
  • 11.6.2 Pharmaceutical Product Development, LLC Business Overview
  • 11.6.3 Pharmaceutical Product Development, LLC Clinical Trials Introduction
  • 11.6.4 Pharmaceutical Product Development, LLC Revenue in Clinical Trials Business (2015-2020)
  • 11.6.5 Pharmaceutical Product Development, LLC Recent Development
• 11.7 Wuxi AppTec Inc.
  • 11.7.1 Wuxi AppTec Inc. Company Details
  • 11.7.2 Wuxi AppTec Inc. Business Overview
  • 11.7.3 Wuxi AppTec Inc. Clinical Trials Introduction
  • 11.7.4 Wuxi AppTec Inc. Revenue in Clinical Trials Business (2015-2020)
  • 11.7.5 Wuxi AppTec Inc. Recent Development
• 11.8 PRA Health Sciences
  • 11.8.1 PRA Health Sciences Company Details
  • 11.8.2 PRA Health Sciences Business Overview
  • 11.8.3 PRA Health Sciences Clinical Trials Introduction
  • 11.8.4 PRA Health Sciences Revenue in Clinical Trials Business (2015-2020)
  • 11.8.5 PRA Health Sciences Recent Development
• 11.9 Chiltern International Ltd.
  • 11.9.1 Chiltern International Ltd. Company Details
  • 11.9.2 Chiltern International Ltd. Business Overview
  • 11.9.3 Chiltern International Ltd. Clinical Trials Introduction
  • 11.9.4 Chiltern International Ltd. Revenue in Clinical Trials Business (2015-2020)
  • 11.9.5 Chiltern International Ltd. Recent Development
• 11.10 INC Research
  • 11.10.1 INC Research Company Details
  • 11.10.2 INC Research Business Overview
  • 11.10.3 INC Research Clinical Trials Introduction
  • 11.10.4 INC Research Revenue in Clinical Trials Business (2015-2020)
  • 11.10.5 INC Research Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Clinical Trials Scope and Market Size
Clinical Trials market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Phase I
Phase II
Phase III
Phase IV

Market segment by Application, split into
Interventional
Observational
Expanded Access

Based on regional and country-level analysis, the Clinical Trials market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Clinical Trials market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Quintiles IMS
Paraxel International Corporation
Charles River Laboratories
ICON plc
SGS SA
Pharmaceutical Product Development, LLC
Wuxi AppTec Inc.
PRA Health Sciences
Chiltern International Ltd.
INC Research